 | • レポートコード：QY20ST-07171 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の店頭販売（OTC）薬・栄養補助食品市場について種類別（鎮痛・鎮痛剤、皮膚科製品、咳、風邪、インフルエンザ製品、ビタミンサプリメント、ミネラルサプリメント、眼科製品）、用途別（薬局、食料品店、ビタミン、健康食品店、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・店頭販売（OTC）薬・栄養補助食品市場の概要 ・世界の主要地域別店頭販売（OTC）薬・栄養補助食品市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の店頭販売（OTC）薬・栄養補助食品市場規模2015-2026：種類別（鎮痛・鎮痛剤、皮膚科製品、咳、風邪、インフルエンザ製品、ビタミンサプリメント、ミネラルサプリメント、眼科製品） ・世界の店頭販売（OTC）薬・栄養補助食品市場規模2015-2026：用途別（薬局、食料品店、ビタミン、健康食品店、オンライン薬局） ・店頭販売（OTC）薬・栄養補助食品の北米市場規模2015-2020 ・店頭販売（OTC）薬・栄養補助食品のヨーロッパ市場規模2015-2020 ・店頭販売（OTC）薬・栄養補助食品の中国市場規模2015-2020 ・店頭販売（OTC）薬・栄養補助食品の日本市場規模2015-2020 ・店頭販売（OTC）薬・栄養補助食品の東南アジア市場規模2015-2020 ・店頭販売（OTC）薬・栄養補助食品のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・店頭販売（OTC）薬・栄養補助食品の製造コスト分析 ・販売チャネル、流通業者、顧客 ・店頭販売（OTC）薬・栄養補助食品の市場動向・機会・課題 ・調査の結論 |
Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Dietary supplements are products intended to supplement the diet. They are not drugs and, therefore, are not intended to treat, diagnose, mitigate, prevent, or cure diseases. This report analyzed both OTC drugs and dietary supplements.
Market Analysis and Insights: Global Over the Counter (OTC) Drugs & Dietary Supplements Market
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Over the Counter (OTC) Drugs & Dietary Supplements market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Over the Counter (OTC) Drugs & Dietary Supplements industry.
Based on our recent survey, we have several different scenarios about the Over the Counter (OTC) Drugs & Dietary Supplements YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Over the Counter (OTC) Drugs & Dietary Supplements will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
Global Over the Counter (OTC) Drugs & Dietary Supplements Scope and Market Size
The global Over the Counter (OTC) Drugs & Dietary Supplements market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Over the Counter (OTC) Drugs & Dietary Supplements market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into
Analgesic & pain relievers
Dermatological products
Cough, cold, and flu products
Vitamin supplements
Mineral Supplements
Ophthalmic Products
Segment by Application, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into
Pharmacies
Grocery Stores
Vitamin
Health Food Stores
Online Pharmacies
The Over the Counter (OTC) Drugs & Dietary Supplements market is analysed and market size information is provided by regions (countries). Segment by Application, the Over the Counter (OTC) Drugs & Dietary Supplements market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Over the Counter (OTC) Drugs & Dietary Supplements Market Share Analysis
Over the Counter (OTC) Drugs & Dietary Supplements market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Over the Counter (OTC) Drugs & Dietary Supplements business, the date to enter into the Over the Counter (OTC) Drugs & Dietary Supplements market, Over the Counter (OTC) Drugs & Dietary Supplements product introduction, recent developments, etc.
The major vendors covered:
Pfizer Inc.
Novartis International AG
Roche Holding AG
Merck & Co., Inc.
Sanofi S.A
Johnson & Johnson
Gilead Sciences
GlaxoSmithKline plc.
Bayer Healthcare AG
AstraZeneca plc.
Alacer Corp.
Alcon Inc.
Alfresa Pharma Corporation
Alkalon A/S
Alliance Healthcare
Allergan, Plc.
Reckitt Benckiser Plc.
Bausch & Lomb
AbbVie Inc.
The Colgate-Palmolive Company
1 Over the Counter (OTC) Drugs & Dietary Supplements Market Overview
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Product Scope
1.2 Over the Counter (OTC) Drugs & Dietary Supplements Segment by Type
1.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2020-2026)
1.2.2 Analgesic & pain relievers
1.2.3 Dermatological products
1.2.4 Cough, cold, and flu products
1.2.5 Vitamin supplements
1.2.6 Mineral Supplements
1.2.7 Ophthalmic Products
1.3 Over the Counter (OTC) Drugs & Dietary Supplements Segment by Application
1.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Comparison by Application (2020-2026)
1.3.2 Pharmacies
1.3.3 Grocery Stores
1.3.4 Vitamin
1.3.5 Health Food Stores
1.3.6 Online Pharmacies
1.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts (2015-2026)
1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Growth Rate (2015-2026)
1.4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue and Growth Rate (2015-2026)
1.4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Over the Counter (OTC) Drugs & Dietary Supplements Industry Impact
1.5.1 How the Covid-19 is Affecting the Over the Counter (OTC) Drugs & Dietary Supplements Industry
1.5.1.1 Over the Counter (OTC) Drugs & Dietary Supplements Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Over the Counter (OTC) Drugs & Dietary Supplements Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Over the Counter (OTC) Drugs & Dietary Supplements Players to Combat Covid-19 Impact
2 Over the Counter (OTC) Drugs & Dietary Supplements Estimate and Forecast by Region
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
2.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2015-2020)
2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2015-2026)
2.4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2015-2026)
2.4.3 China Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2015-2026)
2.4.4 Japan Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2015-2026)
2.4.6 India Over the Counter (OTC) Drugs & Dietary Supplements Estimates and Projections (2015-2026)
3 Global Over the Counter (OTC) Drugs & Dietary Supplements Competition Landscape by Players
3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Sales (2015-2020)
3.2 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2015-2020)
3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2019)
3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Average Price by Company (2015-2020)
3.5 Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Over the Counter (OTC) Drugs & Dietary Supplements Players (Opinion Leaders)
4 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Review by Type (2015-2020)
4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2015-2020)
4.1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2014-2020)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
4.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Type (2021-2026)
5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Review by Application (2015-2020)
5.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
5.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2015-2020)
5.1.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
5.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)
3 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures
3.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
3.3 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
3.4 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures
4.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
4.3 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
4.4 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
5 China Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures
5.2 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
5.3 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
5.4 China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
6 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures
6.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
6.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
6.4 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
7 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures
7.2 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
8 India Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures
8.2 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
8.3 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
8.4 India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Over the Counter (OTC) Drugs & Dietary Supplements Business
12.1 Pfizer Inc.
12.1.1 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.1.2 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.1.3 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.1.5 Pfizer Inc. Recent Development
12.2 Novartis International AG
12.2.1 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.2.2 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.2.3 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.2.5 Novartis International AG Recent Development
12.3 Roche Holding AG
12.3.1 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.3.2 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.3.3 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.3.5 Roche Holding AG Recent Development
12.4 Merck & Co., Inc.
12.4.1 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.4.2 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.4.3 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.4.5 Merck & Co., Inc. Recent Development
12.5 Sanofi S.A
12.5.1 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.5.2 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.5.3 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.5.5 Sanofi S.A Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.6.2 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.6.3 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Gilead Sciences
12.7.1 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.7.2 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.7.3 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.7.5 Gilead Sciences Recent Development
12.8 GlaxoSmithKline plc.
12.8.1 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.8.2 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.8.3 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.8.5 GlaxoSmithKline plc. Recent Development
12.9 Bayer Healthcare AG
12.9.1 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.9.2 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.9.3 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.9.5 Bayer Healthcare AG Recent Development
12.10 AstraZeneca plc.
12.10.1 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.10.2 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.10.3 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.10.5 AstraZeneca plc. Recent Development
12.11 Alacer Corp.
12.11.1 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.11.2 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.11.3 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.11.5 Alacer Corp. Recent Development
12.12 Alcon Inc.
12.12.1 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.12.2 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.12.3 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.12.5 Alcon Inc. Recent Development
12.13 Alfresa Pharma Corporation
12.13.1 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.13.2 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.13.3 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.13.5 Alfresa Pharma Corporation Recent Development
12.14 Alkalon A/S
12.14.1 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.14.2 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.14.3 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.14.5 Alkalon A/S Recent Development
12.15 Alliance Healthcare
12.15.1 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.15.2 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.15.3 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.15.5 Alliance Healthcare Recent Development
12.16 Allergan, Plc.
12.16.1 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.16.2 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.16.3 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.16.5 Allergan, Plc. Recent Development
12.17 Reckitt Benckiser Plc.
12.17.1 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.17.2 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.17.3 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.17.5 Reckitt Benckiser Plc. Recent Development
12.18 Bausch & Lomb
12.18.1 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.18.2 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.18.3 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.18.5 Bausch & Lomb Recent Development
12.19 AbbVie Inc.
12.19.1 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.19.2 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.19.3 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.19.4 AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.19.5 AbbVie Inc. Recent Development
12.20 The Colgate-Palmolive Company
12.20.1 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Corporation Information
12.20.2 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Business Overview and Total Revenue
12.20.3 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales, Revenue and Gross Margin (2015-2020)
12.20.4 The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.20.5 The Colgate-Palmolive Company Recent Development
13 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Cost Analysis
13.1 Over the Counter (OTC) Drugs & Dietary Supplements Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Over the Counter (OTC) Drugs & Dietary Supplements
13.4 Over the Counter (OTC) Drugs & Dietary Supplements Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Over the Counter (OTC) Drugs & Dietary Supplements Distributors List
14.3 Over the Counter (OTC) Drugs & Dietary Supplements Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) Growth Rate by Type (2020-2026)
Table 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Over the Counter (OTC) Drugs & Dietary Supplements Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Over the Counter (OTC) Drugs & Dietary Supplements Players to Combat Covid-19 Impact
Table 8. Global Market Over the Counter (OTC) Drugs & Dietary Supplements Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Region (2015-2020)
Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Region (2015-2020)
Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) Forecast by Region (2021-2026)
Table 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share Forecast by Region (2021-2026)
Table 17. Global Over the Counter (OTC) Drugs & Dietary Supplements (K MT) of Key Companies (2015-2020)
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Company (2015-2020)
Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Company (2015-2020)
Table 21. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2019)
Table 22. Global Over the Counter (OTC) Drugs & Dietary Supplements Average Price (USD/MT) of Key Company (2015-2020)
Table 23. Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Sites and Area Served
Table 24. Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Over the Counter (OTC) Drugs & Dietary Supplements Players
Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2015-2020)
Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Price (K MT) by Type (2015-2020)
Table 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2021-2026)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2026)
Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Price (K MT) by Type (2021-2026)
Table 35. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2015-2020)
Table 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2015-2020)
Table 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Over the Counter (OTC) Drugs & Dietary Supplements Price (K MT) by Application (2015-2020)
Table 39. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2021-2026)
Table 40. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2021-2026)
Table 41. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2026)
Table 43. Global Over the Counter (OTC) Drugs & Dietary Supplements Price (K MT) by Application (2021-2026)
Table 44. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Company (2015-2020)
Table 45. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
Table 46. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 47. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 48. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2015-2020)
Table 49. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 50. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Company (2015-2020)
Table 51. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
Table 52. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 53. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 54. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2015-2020)
Table 55. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 56. China Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Company (2015-2020)
Table 57. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
Table 58. China Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 59. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 60. China Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2015-2020)
Table 61. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 62. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Company (2015-2020)
Table 63. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
Table 64. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 65. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 66. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2015-2020)
Table 67. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Company (2015-2020)
Table 69. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 71. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 73. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 74. India Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Company (2015-2020)
Table 75. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company (2015-2020)
Table 76. India Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 77. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
Table 78. India Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2015-2020)
Table 79. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
Table 80. Pfizer Inc. Corporation Information
Table 81. Pfizer Inc. Description and Business Overview
Table 82. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 84. Pfizer Inc. Recent Development
Table 85. Novartis International AG Corporation Information
Table 86. Novartis International AG Description and Business Overview
Table 87. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 89. Novartis International AG Recent Development
Table 90. Roche Holding AG Corporation Information
Table 91. Roche Holding AG Description and Business Overview
Table 92. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 94. Roche Holding AG Recent Development
Table 95. Merck & Co., Inc. Corporation Information
Table 96. Merck & Co., Inc. Description and Business Overview
Table 97. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 99. Merck & Co., Inc. Recent Development
Table 100. Sanofi S.A Corporation Information
Table 101. Sanofi S.A Description and Business Overview
Table 102. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 104. Sanofi S.A Recent Development
Table 105. Johnson & Johnson Corporation Information
Table 106. Johnson & Johnson Description and Business Overview
Table 107. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 109. Johnson & Johnson Recent Development
Table 110. Gilead Sciences Corporation Information
Table 111. Gilead Sciences Description and Business Overview
Table 112. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 114. Gilead Sciences Recent Development
Table 115. GlaxoSmithKline plc. Corporation Information
Table 116. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. GlaxoSmithKline plc. Description and Business Overview
Table 118. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 119. GlaxoSmithKline plc. Recent Development
Table 120. Bayer Healthcare AG Corporation Information
Table 121. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 122. Bayer Healthcare AG Description and Business Overview
Table 123. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 124. Bayer Healthcare AG Recent Development
Table 125. AstraZeneca plc. Corporation Information
Table 126. AstraZeneca plc. Description and Business Overview
Table 127. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 129. AstraZeneca plc. Recent Development
Table 130. Alacer Corp. Corporation Information
Table 131. Alacer Corp. Description and Business Overview
Table 132. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 134. Alacer Corp. Recent Development
Table 135. Alcon Inc. Corporation Information
Table 136. Alcon Inc. Description and Business Overview
Table 137. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 139. Alcon Inc. Recent Development
Table 140. Alfresa Pharma Corporation Corporation Information
Table 141. Alfresa Pharma Corporation Description and Business Overview
Table 142. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 144. Alfresa Pharma Corporation Recent Development
Table 145. Alkalon A/S Corporation Information
Table 146. Alkalon A/S Description and Business Overview
Table 147. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 149. Alkalon A/S Recent Development
Table 150. Alliance Healthcare Corporation Information
Table 151. Alliance Healthcare Description and Business Overview
Table 152. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 154. Alliance Healthcare Recent Development
Table 155. Allergan, Plc. Corporation Information
Table 156. Allergan, Plc. Description and Business Overview
Table 157. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 159. Allergan, Plc. Recent Development
Table 160. Reckitt Benckiser Plc. Corporation Information
Table 161. Reckitt Benckiser Plc. Description and Business Overview
Table 162. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 164. Reckitt Benckiser Plc. Recent Development
Table 165. Bausch & Lomb Corporation Information
Table 166. Bausch & Lomb Description and Business Overview
Table 167. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Bausch & Lomb Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 169. Bausch & Lomb Recent Development
Table 170. AbbVie Inc. Corporation Information
Table 171. AbbVie Inc. Description and Business Overview
Table 172. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. AbbVie Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 174. AbbVie Inc. Recent Development
Table . The Colgate-Palmolive Company Corporation Information
Table . The Colgate-Palmolive Company Description and Business Overview
Table . The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table . The Colgate-Palmolive Company Over the Counter (OTC) Drugs & Dietary Supplements Product
Table . The Colgate-Palmolive Company Recent Development
Table 180. Production Base and Market Concentration Rate of Raw Material
Table 181. Key Suppliers of Raw Materials
Table 182. Over the Counter (OTC) Drugs & Dietary Supplements Distributors List
Table 183. Over the Counter (OTC) Drugs & Dietary Supplements Customers List
Table 184. Market Key Trends
Table 185. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 186. Key Challenges
Table 187. Research Programs/Design for This Report
Table 188. Key Data Information from Secondary Sources
Table 189. Key Data Information from Primary Sources
List of Figures
Figure 1. Over the Counter (OTC) Drugs & Dietary Supplements Product Picture
Figure 2. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Application in 2020 & 2026
Figure 6. Pharmacies Examples
Figure 7. Grocery Stores Examples
Figure 8. Vitamin Examples
Figure 9. Health Food Stores Examples
Figure 10. Online Pharmacies Examples
Figure 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) Growth Rate (2015-2026)
Figure 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) Growth Rate (2015-2026)
Figure 18. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Over the Counter (OTC) Drugs & Dietary Supplements Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Over the Counter (OTC) Drugs & Dietary Supplements Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Over the Counter (OTC) Drugs & Dietary Supplements Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Over the Counter (OTC) Drugs & Dietary Supplements Players Market Share by Revenue in Over the Counter (OTC) Drugs & Dietary Supplements 2015 & 2019
Figure 29. Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2015-2020)
Figure 31. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2015-2020)
Figure 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 35. United States Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 36. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company in 2019
Figure 37. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 38. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2019
Figure 39. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company in 2019
Figure 40. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 41. China Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2019
Figure 42. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company in 2019
Figure 43. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 44. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2019
Figure 45. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company in 2019
Figure 46. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 47. Southeast Asia Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2019
Figure 48. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Company in 2019
Figure 49. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type in 2019
Figure 50. India Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application in 2019
Figure 51. Pfizer Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Novartis International AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Roche Holding AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Sanofi S.A Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Gilead Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. GlaxoSmithKline plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Bayer Healthcare AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. AstraZeneca plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Alacer Corp. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Alcon Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Alfresa Pharma Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Alkalon A/S Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Alliance Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 66. Allergan, Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 67. Reckitt Benckiser Plc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 68. Bausch & Lomb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 69. AbbVie Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 70. The Colgate-Palmolive Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 71. Key Raw Materials Price Trend
Figure 72. Manufacturing Cost Structure of Over the Counter (OTC) Drugs & Dietary Supplements
Figure 73. Manufacturing Process Analysis of Over the Counter (OTC) Drugs & Dietary Supplements
Figure 74. Over the Counter (OTC) Drugs & Dietary Supplements Industrial Chain Analysis
Figure 75. Channels of Distribution
Figure 76. Distributors Profiles
Figure 77. Porter's Five Forces Analysis
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
市販（OTC）薬の世界市場レポート2020 Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a prescription from a healthcare professional, as opposed to prescription drugs, which may be sold only to consumers possessing a valid prescription. Market Analysis and Insights: Global Over The Counter (OTC) Drugs Marke…- 人間用栄養補助食品の世界市場レポート2020 Human Dietary Supplements can be taken orally by consumers who are unable to meet their nutritional needs through regular diet. Geographically, Asia-Pacific is the largest market for dietary supplements. Market Analysis and Insights: Global Human Dietary Supplements Market Since the COVID-19 virus o…
- プロバイオティクスベース栄養補助食品の世界市場レポート2020 A recently published report by QY Research titled Global Probiotic-based Dietary Supplements Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically …
- 妊娠用ビタミン・サプリメントの世界市場レポート2020 A recently published report by QY Research titled Global Pregnant Vitamin and Supplements Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically pro…
- 高エナジー補助食品の世界市場レポート2020 High Energy Supplements do not form a unified whole with food like nutritional fortifiers, and most of them are made into pills, tablets, capsules, infusion or oral liquid, which are taken with meals alone.They are not the usual foods, nor are they nutritional enhancers.Nutritional supplements may c…